EMA Grants Orphan Designation to Can-Fite's CF102 in the Treatment of Liver Cancer
October 12, 2015 at 07:06 AM EDT
Can-Fite BioPharma Ltd. (NYSE MKT: CANF) today announced the Company's oncology drug candidate, CF102, has been granted Orphan Drug ...